Roche Diagnostics' Sales Rise 4 Percent as Applied Science Unit Continues to Struggle | GenomeWeb

NEW YORK (GenomeWeb News) – Roche today reported that sales for its diagnostics division grew 4 percent year over year at constant exchange rates for the first nine months of 2012, with molecular diagnostics showing single-digit growth and the applied science unit continuing to struggle.

For the nine months ended Sept. 30, Roche reported total diagnostics sales of CHF 7.50 billion ($8.09 billion) compared to CHF 7.10 billion for the first nine months of 2011. In Swiss francs its diagnostics sales were up 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.